NFM Lending welcomes Petros Christophilis as Branch Manager in Seattle, WA
03 mai 2024 13h37 HE
|
NFM Lending
Linthicum, May 03, 2024 (GLOBE NEWSWIRE) -- LINTHICUM, MD, May 3, 2024 — NFM Lending is pleased to announce the opening of a new branch led by Branch Manager Petros Christophilis. The branch is...
Research Presented at AUA 2024 Indicates Vasectomies Have Increased Since Dobbs Decision
03 mai 2024 12h00 HE
|
American Urological Association
SAN ANTONIO, May 03, 2024 (GLOBE NEWSWIRE) -- Abstracts presented at the American Urological Association's Annual Meeting show increased vasectomy consults and procedures since the Dobbs decision in...
TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
03 mai 2024 11h53 HE
|
Janssen Cilag International NV
New data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98 percent achieving a CR within 12 weeks1 TAR-200 provides durable CRs in patients with Bacillus...
CISO Leadership: Making GenAI Initiatives Safe and Secure will Pepper the Discussion at HMG Strategy’s 8th Annual New York CISO & Technology Leadership Summit on June 11
03 mai 2024 10h29 HE
|
HMG Strategy
WESTPORT, Conn., May 03, 2024 (GLOBE NEWSWIRE) -- HMG Strategy, the World’s #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to...
Studies Indicate Environmental Factors Can Impact Urologic Health
03 mai 2024 08h21 HE
|
American Urological Association
SAN ANTONIO, May 03, 2024 (GLOBE NEWSWIRE) -- Abstracts being presented at the American Urological Association's Annual Meeting show microplastic particles have been found in many human tissues...
PDS Biotechnology Announces Details of Virtual KOL Event
03 mai 2024 08h00 HE
|
PDS Biotechnology Corporation
PRINCETON, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
03 mai 2024 07h30 HE
|
MacroGenics, Inc.
ROCKVILLE, MD, May 03, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
03 mai 2024 07h30 HE
|
Ocular Therapeutix, Inc.
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of...
TransAlta Reports First Quarter 2024 Results
03 mai 2024 07h04 HE
|
TransAlta Corporation
CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) today reported its financial results for the first quarter ended March...
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
03 mai 2024 07h00 HE
|
BeyondSpring, Inc.
FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing...